Overview
Prudentia Sciences raised $20 million in Series A financing to enhance its AI-native due diligence platform for life sciences dealmaking. This funding aims to assist pharmaceutical companies, biotechs, and financial institutions in evaluating therapeutic assets more efficiently and rigorously. The investment will support the company's growth in addressing critical challenges in the industry.
Products
Loading...
Recent Deals
Prudentia Sciences raised $20 million in Series A financing to enhance its AI-native due diligence platform for life sciences dealmaking. This funding aims to assist pharmaceutical companies, biotechs, and financial institutions in evaluating therapeutic assets more efficiently and rigorously. The investment will support the company's growth in addressing critical challenges in the industry.